Cluster 1 was characterized by KMT2A fusion partners MLLT3 and MLLT10, whereas Cluster 3 comprised mainly ELL and MLLT4. Interestingly, all LS AML samples were assigned to Cluster 2, which contained various other fusion partners. The gene discussed is MLLT3; the disease is Leigh syndrome.